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EXPERIMENTALLY INDUCED REACTIONS TO ULTRAVIOLET LIGHT
I. POLYMORPHOUS LIGHT ERUPTION AND
PHOTOTOXICITY TO DRUGS*
MILTON M. CAHN, M.D., EDWIN J. LEVY, M.D.
AND BERTRAM SHAFFER, M.D., D.Sc. (Med.)
Experimentally induced reactions to ultra-
violet light have been demonstrated in patients
with various diseases due to sunlight sensitivity
(1—5). These have included phototoxic and photo-
allergic effects (6) and have been observed in
urtiearia solare (7), contact eczematous photo-
sensitization (8), drug photosensitization (4, 5, 9,
10) and polymorphous light eruptions (3, 11).
This paper attempts to summarize our experi-
ence with experimentally induced reactions to
ultraviolet light in patients with polymorphous
light eruption and in certain drug photosensitiza-
tions, and to give a possible explanation for their
occurrence.
The action spectrum for erythema production
with ultraviolet light shows that erythema is
produced only by wave lengths within narrow
zones about 2500 and 2967 A. (Fig. 1). Sunlight
reaching the earth has a continuous spectrum
which emits erythemogenic rays above 2900 A.,
but the precise wave lengths and intensity to
reach a particular area are dependent upon many
factors, including atmospheric conditions, geo-
graphic locality and season of the year. The emis-
sions of a carbon arc lamp approach that of a
continuous spectrum, the spectral distribution
being dependent on the type of carbon used (12).
The "C" carbon gives strong emissions in the
ultraviolet zone between 2900 and 3200 A. A hot
quartz ultraviolet lamp has a line spectral emis-
sion with strong bands in this erythemogenic
zone (Fig. 2).
NORMAL SUNBURN ERvTHEMA
The normal reaction of the skin to ultraviolet
light in the sunburn spectrum (2900—3200 A.) is
erythema which does not appear immediately
after exposure, but appears after a latent period
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of two to eight hours and reaches maximum
intensity in 24 to 48 hours. Depending on the
dose, edema, vesiculation, scaling and pigmenta-
tion occur. Normal variations occur, depending
on duration and intensity of radiation, individual
complexion, epidermal thickness and prior expo-
sure. Experimentally, intensity, duration, and
distance from the light source are factors that
may be controlled. However, differences in
complexion and epidermal thickness may cause
the erythema producing dose to vary from indi-
vidual to individual. The minimal erythema dose
(M.E.D.), also known as the minimal perceptible
erythema (M.P.E.), may be defined as the
amount of ultraviolet light required to produce a
barely perceptible erythema in 24 hours. If
valid results are to be expected, the minimal
erythema dose must be determined for each
individual each time a particular light source is
used.
Erythema is the macroscopic manifestation of
dilatation of the minute blood vessels of the
eorium. Since the wave lengths of the sunburn
spectrum do not penetrate beneath the epidermis
in any substantial amount, the erythematous
response cannot be a direct effect of the ultra-
violet light on these dermal vessels. It must
therefore result from the action on these blood
vessels of some agent released by the epidermal
cells after they absorbed the ultraviolet energy
(13). The quantity of ultraviolet light absorbed
in the epidermis determines the degree of the
photoehemical reaction, and this in turn deter-
mines the amount of released vasodilator sub-
stances. While the nature of these dilator sub-
stances is as yet unknown, there is reason to
believe that they are neither histamine nor
histamine-like substances (14, 15). Histologically,
a non-specific inflammatory reaction is seen
which not only involves the sub-epidermal zone
but also extends deeply into the eorium.
CHRONIC POLYMORPHOUS LIGHT ERUPTIONS
Sunlight may provoke a diversity of reactions
in predisposed persons, including eezematous
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lesions, papules, plaques, verrucoid growths and
bullae. The term polymorphous light eruption
is used to describe certain of these (16). The
clinical types most often seen are the eczematous
and the erythematopapular forms.
Contact Eczematou.s Type of Polymorphous Light
Eruption
This eruption appears on the exposed portions
of the body and is difficult to distinguish from
contact eczematous dermatitis or contact photo-
sensitivity. This type is also known as eczema
solare. There is a history of an outbreak in body
areas exposed to sunlight usually in spring and
summer when sunlight contains wave lengths in
the sunburn spectrum. The eruption subsides
with the usc of sun protective measures. Histo-
pathologic examination shows the same features
as seen in contact dermatitis.
Erythematopaputar Type of Polymorphous Light
Eruption
This type is known by a variety of names,
including summer prurigo, prurigo aestivalis,
erythema perstans solare, and Hutchinson's
summer eruption. It is characterized by pruritic
urticaria-like papular and nodular lesions on
those portions of the body exposed to sunlight.
The disease begins in late spring or early summer
and usually terminates spontaneously in the
fall. This type often resembles subacute lupus
erythcmatosus (1).
In some patients with the papular and plaque-
like type of polymorphous light eruption we have
been able to reproduce their eruption experimen-
tally in test sites by exposures to five or more
M.E.D. of ultraviolet light in the sunburn
spectrum.
The histopathologic pictures in the clinical
and the experimentally reproduced eruptions are
similar and show hyperkeratosis, follicular plug-
ging, atrophy of the rcte malpighii, liquefaction
degeneration of the basal cell layer, edema of the
upper part of the corium with capillary dilatation,
and perivascular and pcriappendigeal lympho-
cytic infiltration. Thus, the histologic picture may
also resemble that of lupus erythematosus (1).
When the eruption is experimentally repro-
duced, certain alterations occur in the erythemic
response to ultraviolet light. The erythema
persists beyond the usual three to five days and
instead lasts for seven to ten days. This erythema
has a distinctive and intense orange-red color
(Fig. 3). The peculiar nature of this erythema is
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FIG. 1. Action spectrum for erythema produc-
tion with ultraviolet light (after Blum).
WAVE-LENGTH A)
FIG. 2. "5" represents spectral distribution of
sunlight. "C"—spectral emission from a "C"
carbon-arc lamp. W. G.—lower wave length limit
of transmission by window-glass. The vertical
lines represent the posltion of the principal
mercury lines from the hot quartz ultraviolet light
and their relative intensities.
FIG. 3. Intense erythema which preceeds the papular eruption in test sites. Note
beginning papule formation.
FIG. 4. Erythematopapular form of polymorphous light eruption.
FIG. 5. Papules in test sites. Reproduced by 10 MED. of carbon arc light (left),
and 10 MED. of hot quartz ultraviolet light (right).
Figure 3
Figure 4
Figure 5
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a characteristic feature, and when it is seen one
can predict that papules will subsequently ap-
pear. It is also characteristic of the reproduced
erythema that it is not replaced by pigmentation.
This reaction has not been reproduced in the
skin of normal subjects.
The eruption cannot he reproduced in every
patient who has polymorphous light eruption.
Several factors may explain this inability to
reproduce it in all patients: (a) the skin test area
may have been relatively resistant at the time of
the test; (b) the patient may be in a refractory
state, since periods of refractoriness may alternate
with phases of "sensitization" and one is unable
to reproduce the eruption during these refractory
periods (2, 13, 17); (c) the patient may be specif-
ically sensitive to a wave length absent in the
line type hot quartz mercury arc lamp. On the
other hand, even if the particular band were
present (as from a carbon arc lamp) its rays may
be of insufficient intensity.
We have been able to reproduce this eruption
only with rays within the sunburn spectrum.
However, other investigators believe that the
critical spectral range may be above 3200 A.
(18—20). The following experiment was done in
an attempt to reproduce the eruption with ultra-
violet rays above 3200 A.
CASE REPORT
A 35 year old white man with a history of
polymorphous light eruption each summer for the
preceding six years (Fig. 4), was exposed to ten
erythema doses of ultraviolet light, delivered to
separate two cm. circular areas on the upper back
by a carbon arc lamp and by a hot quartz mer-
cury vapor lamp. Both lamps produced intense
erythema in 24 hours and this persisted for one
week, after which papules gradually replaced the
erythema (Fig. 5). Exposures from the two light
sources then were given to two other test sites on
the upper back through a filter which eliminated
rays below 3200 A. In spite of the fact that the
dose delivered corresponded to 80 MED. of un-
filtered ultraviolet light, no reactions were ob-
served in the test sites. The patient was then
exposed to a Kromayer air-cooled lamp, at con-
tact, through the same filter, with a dose cor-
responding to 1000 MED. of unfiltered ultra-
violet light. Intense erythema developed at once
from the heat, but soon began to fade, so that after
24 hours only a mild erythema remained. This
disappeared within 48 hours.
S\Te believe this reaction was due to intense
heat since it appeared immediately, in contrast
to sunburn erythema which appears after a latent
period. No further reactions occurred in this test
site after three weeks of observation. Thus it is
apparent that this patient did not develop altered
reactivity characteristic of polymorphous light
eruption in test sites when exposed to ultraviolet
light rays above 3200 A. even though the meas-
ured intensity of these ultraviolet light radiations
were twice as great above 3200 A., as determined
by means of an ultraviolet light intensity meter.
In patients with polymorphous light eruption
we have observed some unusual reactions in
ultraviolet light test sites. We have previously
reported experimental work on a group of 27
patients in whom the characteristic papular
response was produced in eight, while other
unusual reactions developed in four (3). Two of
the four patients had prolonged, persistent
erythema for several months with lack of pigmen-
tation or papules. This may represent a chronic
dilatation of the minute blood vessels of the
corium as a result of vascular damage from ultra-
violet light. In the third and fourth patients
sunlight produced not only a flare of polymor-
phous light eruption in exposed body areas but
also resulted in a concomitantly produced papular
eruption in previously tested skin sites which were
not reexposed.
The administration of the antimalarial drugs
does not alter the minimal erythema response
of the skin either in normal individuals or in
patients with polymorphous light eruption (21).
However, they do inhibit polymorphous light
eruption and normal pigmentation occurs (22—
24). They also inhibit the abnormal preliminary
intense erythema seen before papules develop, as
well as the inflammatory papular reaction in
experimental test sites. In the two patients with
persistent erythema, ebloroquine did not alter
this reaction.
PIIOTOTOXIC REACTIONS TO DRUGS
Phototoxie reactions to sunlight are not uncom-
mon and have been documented in the ease of
certain drugs, such as sulfanilamide (6, 25).
Recently, we have observed reactions to chlor-
promazine, and triflupromazine, in which there
was an increased sunburn reaction manifest ex-
perimentally by a decrease in the amount of ul-
traviolet light needed to produce a minimal
erythema. In a group of 105 people taking ehlor-
promazine, five exhibited this heightened reaction
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to the sunburn rays of summer sunlight (4). J.
Epstein, et at. confirmed this experimentally (9).
Of 70 men taking Vesprin (trifiupromazine,
Squibb), one showed phototoxicity, as exhibited
by a heightened erythemie response to ultra-
violet light rays in the sunburn spectrum (5). This
reaction was absent when radiation below 3200
A. was excluded. On the other hand, S. Epstein
recently reported a ease in which the photo-
toxicity to ehlorpromazine was induced by light
of wave lengths over 3200 A. (10).
CONCLUSIONS
The following table summarizes the various
types of experimentally induced reactions to
ultraviolet light.
I. Normal reaction: Erythema and pigmenta-
tion.
II. Reactions of hypersensitivity
a. Phototoxie reactions. Enhancement of
the normal erythema (increased "sunburn
reaction".)
b. Immediate urtiearial reactions (urtiearia
solare). Allergic; non-allergic?
e. Delayed papular reactions. (Papular and
plaque types of polymorphous light
eruption). Allergic.
d. Eezematous contact reactions (eczema
solare). Allergic.
III. Other reactions.
a. Persistent erythema. Non-allergic.
In true phototoxie reactions such as have been
described with certain drugs there is an accelera-
tion or heightening of the normal response to
ultraviolet light (i.e., a decrease in the M.E.D.).
In contrast, patients with polymorphous light
eruption do not show this quantitative difference
in the erythemie response but exhibit a qualita-
tively altered reaction pattern which is mani-
fested by the papular response (i.e., the M.E.D.
is unaltered). This iS one of the cogent reasons for
our hypothesis that polymorphous light eruption
may be a true photoallergie disease (3).
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